EQUILLIUM, INC. (EQ) Net Margin
- 2024-12-31: Net Margin -131.92%.
- 2024-09-30: Net Margin -0.06%.
- 2024-06-30: Net Margin 3.38%.
- 2024-03-31: Net Margin -25.58%.
Complete source-backed net margin history.
- Available history
- 2022-12-31 to 2024-12-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2024-12-31 | -131.92% |
| 2024-09-30 | -0.06% |
| 2024-06-30 | 3.38% |
| 2024-03-31 | -25.58% |
| 2023-12-31 | -25.43% |
| 2023-09-30 | -41.83% |
| 2023-06-30 | -36.64% |
| 2023-03-31 | -44.37% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2024-12-31 | -19.63% |
| 2023-12-31 | -36.96% |
| 2022-12-31 | -396.14% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |